Form D Explorer

Form D — Allotera Therapeutics, Inc.

0001874298-26-000004 · filed Jul 23, 2026

Offering

Industry: Other Health Care
Exemptions: 06b
Total offering: $163,043,971
Total sold: $123,313,778
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Allotera Therapeutics, Inc.
CIK: 1874298
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 4260 FOREST PARK AVE., SUITE 100
ST. LOUIS, MO 63110
Phone: 314-501-1968

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Niall O'Donnell · Director

St. Louis, MO Find on LinkedIn ↗
Bali Muralidhar · Director

St. Louis, MO Find on LinkedIn ↗
Peter Kiener · Director

St. Louis, MO Find on LinkedIn ↗
Drew Dennison · Director

St. Louis, MO Find on LinkedIn ↗
Kevin Li · Director

St. Louis, MO Find on LinkedIn ↗
Bosun Hau · Director

St. Louis, MO Find on LinkedIn ↗
Matthew Cooper · Executive Officer

St. Louis, MO Find on LinkedIn ↗
Ayman Kabakibi · Executive Officer

St. Louis, MO Find on LinkedIn ↗
Natalie Mount · Director

St. Louis, MO Find on LinkedIn ↗
Kumar Srinivasan · Executive Officer

St. Louis, MO Find on LinkedIn ↗
Cherry Thomas · Executive Officer

St. Louis, MO Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗